Response of follicular dendritic cell sarcoma to gemcitabine and docetaxel: report of two cases and literature review

Por Conry, Robert M
Publicado em 2014

Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients

Por Conry, Robert M., Rodriguez, Michael G., Pressey, Joseph G.
Publicado no Clin Sarcoma Res (2016)

Acute inflammatory thyromegaly following checkpoint inhibition: A new imaging entity?

Por Middlebrooks, Erik H., Westbrook, Brian C., Conry, Robert M.
Publicado no Radiol Case Rep (2017)

Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy

Por Marcrom, Samuel, De Los Santos, Jennifer F., Conry, Robert M.
Publicado no Clin Sarcoma Res (2017)

Talimogene laherparepvec: First in class oncolytic virotherapy

Por Conry, Robert M., Westbrook, Brian, McKee, Svetlana, Norwood, Timothy Graham
Publicado no Hum Vaccin Immunother (2018)

Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases

Por Blackmon, Jonathan T., Dhawan, Ratika, Viator, Toni M., Terry, Nina L., Conry, Robert M.
Publicado no JAAD Case Rep (2017)

Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab

Por Kropp, Lauren M., De Los Santos, Jennifer F., McKee, Svetlana B., Conry, Robert M.
Publicado no J Immunother (2016)

Responses to immune checkpoint inhibitors in nonagenarians

Por Johnpulle, Romany A. N., Conry, Robert M., Sosman, Jeffrey A., Puzanov, Igor, Johnson, Douglas B.
Publicado no Oncoimmunology (2016)

Talimogene laherparepvec induces durable response of regionally advanced Merkel cell carcinoma in 4 consecutive patients

Por Westbrook, Brian C., Norwood, T. Graham, Terry, Nina L.J., McKee, Svetlana B., Conry, Robert M.
Publicado no JAAD Case Rep (2019)

Primary Intraosseous Smooth Muscle Tumor of Uncertain Malignant Potential: Original Report and Molecular Characterization

Por Kropp, Lauren, Siegal, Gene P., Frampton, Garrett M., Rodriguez, Michael G., McKee, Svetlana, Conry, Robert M.
Publicado no Rare Tumors (2016)

ECOG Phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma over-expressing basic fibroblast growth factor (E2602)

Por Go, Ronald S., Lee, Sandra J., Shin, Donghoon, Callister, Steven M., Jobe, Dean A., Conry, Robert M., Tarhini, Ahmad A., Kirkwood, John M.
Publicado em 2013

Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

Por Perez, Matthew C, Zager, Jonathan S, Amatruda, Thomas, Conry, Robert, Ariyan, Charlotte, Desai, Anupam, Kirkwood, John M, Treichel, Sheryl, Cohan, David, Raskin, Leon
Publicado no Melanoma Manag (2019)

Correlates of response and outcomes with Talimogene Laherperpvec

Por Zhou, Alice, Wang, Daniel Y, McKee, Svetlana, Ye, Fei, Wen, Chun-Che, Wallace, Debbie E, Ancell, Kristin K, Conry, Robert M., Johnson, Douglas B
Publicado no J Surg Oncol (2019)

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

Por Blackmon, Jonathan T., Stratton, Michael S., Kwak, Young, Pavlidakey, Peter G., Slominski, Andrzej T., McKee, Svetlana B., Viator, Toni M., Kim, Ju Young, Huang, Conway C., Conry, Robert M.
Publicado no JAAD Case Rep (2017)

Smoldering myocarditis following immune checkpoint blockade

Por Norwood, Timothy G., Westbrook, Brian C., Johnson, Douglas B., Litovsky, Silvio H., Terry, Nina L., McKee, Svetlana B., Gertler, Alan S., Moslehi, Javid J., Conry, Robert M.
Publicado no J Immunother Cancer (2017)

A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases

Por Fiveash, John B., Arafat, Waleed O., Naoum, George E., Guthrie, Barton L., Sawrie, Stephen M., Spencer, Sharon A., Meredith, Ruby F., Markert, James M., Conry, Robert M., Nabors, Burt L.
Publicado no Adv Radiat Oncol (2016)

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced Melanoma

Por Tarhini, Ahmad A., Lee, Sandra J., Li, Xiaoxue, Rao, Uma N. M., Nagarajan, Arun, Albertini, Mark R., Mitchell, Jerry W., Wong, Stuart J., Taylor, Mark A., Laudi, Noel, Truong, Phu V., Conry, Robert M., Kirkwood, John M.
Publicado no Clin Cancer Res (2018)

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Por Lebbé, Celeste, Dutriaux, Caroline, Lesimple, Thierry, Kruit, Willem, Kerger, Joseph, Thomas, Luc, Guillot, Bernard, de Braud, Filippo, Garbe, Claus, Grob, Jean-Jacques, Loquai, Carmen, Ferraresi, Virginia, Robert, Caroline, Vasey, Paul, Conry, Robert, Isaacs, Richard, Espinosa, Enrique, Schueler, Armin, Massimini, Giorgio, Dréno, Brigitte
Publicado no Cancers (Basel) (2020)

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncol...

Por Agarwala, Sanjiv S., Lee, Sandra J., Yip, Waiki, Rao, Uma N., Tarhini, Ahmad A., Cohen, Gary I., Reintgen, Douglas S., Evans, Terry L., Brell, Joanna M., Albertini, Mark R., Atkins, Michael B., Dakhil, Shaker R., Conry, Robert M., Sosman, Jeffrey A., Flaherty, Lawrence E., Sondak, Vernon K., Carson, William E., Smylie, Michael G., Pappo, Alberto S., Kefford, Richard F., Kirkwood, John M.
Publicado no J Clin Oncol (2017)

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Por Schwartzentruber, Douglas J., Lawson, David H., Richards, Jon M., Conry, Robert M., Miller, Donald M., Treisman, Jonathan, Gailani, Fawaz, Riley, Lee, Conlon, Kevin, Pockaj, Barbara, Kendra, Kari L., White, Richard L., Gonzalez, Rene, Kuzel, Timothy M., Curti, Brendan, Leming, Phillip D., Whitman, Eric D., Balkissoon, Jai, Reintgen, Douglas S., Kaufman, Howard, Marincola, Francesco M., Merino, Maria J., Rosenberg, Steven A., Choyke, Peter, Vena, Don, Hwu, Patrick
Publicado em 2011